Akebia Therapeutics Files 8-K on Financials
Ticker: AKBA · Form: 8-K · Filed: Mar 13, 2025 · CIK: 1517022
| Field | Detail |
|---|---|
| Company | Akebia Therapeutics, Inc. (AKBA) |
| Form Type | 8-K |
| Filed Date | Mar 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations, filing
Related Tickers: AKBA
TL;DR
AKBA filed an 8-K on 3/13/25 detailing financial results and exhibits.
AI Summary
Akebia Therapeutics, Inc. filed an 8-K on March 13, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the report being as of March 13, 2025. The company is incorporated in Delaware and headquartered in Cambridge, Massachusetts.
Why It Matters
This filing provides an update on Akebia Therapeutics' financial performance and condition, which is crucial for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial filing (8-K) that doesn't appear to disclose any new material events or significant changes.
Key Players & Entities
- Akebia Therapeutics, Inc. (company) — Registrant
- March 13, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Cambridge, Massachusetts (location) — Principal Executive Offices
- 617-871-2098 (phone_number) — Business Phone
FAQ
What is the primary purpose of this 8-K filing for Akebia Therapeutics?
The primary purpose is to report on Akebia Therapeutics, Inc.'s results of operations and financial condition, including financial statements and exhibits.
On what date was this 8-K report filed and as of what date is it effective?
The report was filed on March 13, 2025, and it is effective as of March 13, 2025.
In which U.S. state is Akebia Therapeutics, Inc. incorporated?
Akebia Therapeutics, Inc. is incorporated in Delaware.
What is the principal executive office address for Akebia Therapeutics, Inc.?
The principal executive offices are located at 245 First Street, Cambridge, Massachusetts, 02142.
What is the telephone number for Akebia Therapeutics, Inc.?
The registrant's telephone number, including area code, is (617) 871-2098.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 13, 2025 regarding Akebia Therapeutics, Inc. (AKBA).